Abbott Launches AI-Powered Coronary Imaging Platform in Europe
Abbott’s Portico with Flexnav Tavr System Receives the US FDA’s Approval for the Treatment of Aortic Valve Disease
Shots:
- Abbott’s new imaging platform powered by Ultreon 1.0 software has received a CE mark in the EU. The new imaging platform merges optical coherence tomography (OCT) with AI to enhance visualization and detect the severity of calcium-based blockages and measure vessel diameter
- Ultreon software when integrated with Abbott’s new Dragonfly OpStar imaging catheter allows physicians to capture information from even more complex patient anatomy
- The company plans to showcase the new Ultron software for the first time at the EuroPCR during the company’s “Tools and Technique Sessions’’ and plans to pursue regulatory approval in the US and Japan
Click here to read full press release/ article | Ref: Abbott | Image: Media Post